-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Roivant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Roivant Sciences Ltd. Operating Income (Loss) for the quarter ending September 30, 2024 was -$342M, a 59.8% decline year-over-year.
- Roivant Sciences Ltd. Operating Income (Loss) for the twelve months ending September 30, 2024 was $4.27B.
- Roivant Sciences Ltd. annual Operating Income (Loss) for 2023 was $4.24B.
- Roivant Sciences Ltd. annual Operating Income (Loss) for 2022 was -$1.18B, a 13% increase from 2021.
- Roivant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$1.35B, a 26.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)